Does Pegylated-Interferon Still Have High Efficacy Treatment Properties Against Chronic Hepatitis B?
Objectives: Pegylated-interferon (Peg-IFN) alpha 2a/2b and nucleoside and/or nucleotide analogues (NAs) are currently the only two treatment approaches approved for the chronic hepatitis B (CHB). To date, few studies have compared Peg-IFN with NAs in the treatment of CHB. We aimed in this study to e...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Galenos Publishing House
2018-12-01
|
| سلاسل: | Viral Hepatitis Journal |
| الموضوعات: | |
| الوصول للمادة أونلاين: |
http://viralhepatitisjournal.org/archives/archive-detail/article-preview/does-pegylated-nterferon-still-have-high-efficacy-/21071
|
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|